Stockreport

Flex Pharma launches mid-stage study of FLX-787 in ALS [Seeking Alpha]

FLEX PHARMA  (FLKS) 
Last flex pharma earnings: 8/1 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.flex-pharma.com/investor-overview
PDF Flex Pharma ( FLKS ) initiates a Phase 2 clinical trial, COMMEND , assessing Fast Track-tagged FLX-787 for the treatment of patients with motor neuron disea [Read more]